Fmoc-3-(1-Naphthyl)-D-Alanine

Fmoc-3-(1-Naphthyl)-D-Alanine is an Fmoc-protected D-alanine derivative bearing a stereogenic center at the α-carbon and a bulky 1-naphthyl substituent at the 3-position of the amino acid side chain. The molecule contains an N-(9H-fluoren-9-ylmethoxycarbonyl) protecting group that masks the amine for controlled peptide coupling, along with a carboxylic acid functionality that can be activated for amide bond formation. The aromatic naphthalene ring system introduces strong hydrophobic and π-interaction character, which can influence conformational preferences and binding-site recognition in peptide and peptidomimetic scaffolds. The D-configuration supports stereochemically defined incorporation into sequences and can serve as a chiral building block for downstream derivatization and synthetic intermediate preparation in amino acid chemistry.

1. Peptide Synthesis

Fmoc-3-(1-Naphthyl)-D-Alanine is used in peptide building block workflows where Fmoc deprotection enables subsequent amide coupling under standard protected-amino-acid strategies. The Fmoc group provides orthogonal N-protection relative to carboxyl activation, while the D-α-stereocenter supports stereodefined incorporation into growing peptide chains. The 1-naphthyl side chain functions as a hydrophobic/aromatic motif that can be retained through coupling to generate peptide analogs with enhanced aromatic surface area and altered backbone-side-chain packing. The resulting Fmoc-compatible amino acid derivative can be applied to synthesize D-amino-acid-containing peptides for structure-function studies and scaffold diversification in synthetic peptide chemistry.

2. Peptidomimetics And SAR

Fmoc-3-(1-Naphthyl)-D-Alanine is applicable to peptidomimetic construction and structure-activity relationship studies where aromatic side-chain presentation is a key determinant of molecular recognition. The protected amino acid framework supports systematic substitution at a defined stereocenter, enabling SAR-driven comparisons of D-alanine analogs with distinct hydrophobic bulk from the naphthalene moiety. Fmoc removal and carboxyl activation allow incorporation into constrained or modified peptide backbones, including sequences designed to probe binding-site topology and π-interaction contributions. The naphthyl-bearing D-amino acid intermediate can be employed to generate libraries of peptide analogs for medicinal chemistry design iterations and fragment-to-lead optimization.

3. Chiral Amino Acid Intermediate

Fmoc-3-(1-Naphthyl)-D-Alanine is suitable as a chiral amino acid intermediate for stereoselective synthesis planning in fine chemical and process chemistry contexts. The D-configuration at the α-carbon provides a defined stereochemical handle that can be carried through downstream transformations, including conversion of the carboxyl group to activated esters or amide-forming derivatives for further assembly. The Fmoc-protected amine offers a controllable protection strategy that can be removed when coupling or conjugation chemistry is required, supporting stepwise manufacturing of complex amino acid derivatives. The aromatic naphthalene substituent can also serve as a functional anchor for later derivatization routes, enabling the preparation of chiral, aromatic-rich intermediates for synthetic organic chemistry programs.

4. Chemical Biology Probes

Fmoc-3-(1-Naphthyl)-D-Alanine supports chemical biology research by enabling incorporation of an aromatic naphthalene motif into peptides used as probes for molecular interactions. The Fmoc-protected amine and carboxylic acid functionality facilitate controlled peptide assembly, allowing researchers to position the naphthyl group at a defined residue for studying hydrophobic contacts and π-stacking effects. D-amino acid placement can be used to modulate proteolytic stability and conformational behavior of peptide probes, which can be relevant when designing interaction studies and binding assays. The resulting D-naphthyl-containing peptide building blocks can be applied to generate labeled or functionalized biomolecular constructs for mechanistic investigation and interaction mapping.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-3-(1-Naphthyl)-D-Alanine is relevant to pharmaceutical manufacturing workflows that require protected amino acid inputs for controlled peptide assembly and intermediate preparation. The Fmoc group enables reproducible N-protection during synthesis and supports standardized deprotection/coupling sequences used in peptide manufacturing, while the carboxyl functionality supports conversion into amide-forming intermediates. The bulky 1-naphthyl side chain can be used to introduce aromatic character into peptide drug candidates or peptide-like intermediates, supporting consistent scaffold construction during process development. The compound's defined stereochemistry and protected-group compatibility make it suitable for producing D-amino-acid-containing peptide intermediates used in downstream formulation development and specialty chemical production pipelines.

6. Analytical Research Standards

Fmoc-3-(1-Naphthyl)-D-Alanine can be employed in analytical research and method development as a reference material for monitoring protected amino acid handling, deprotection, and peptide coupling outcomes. The combination of Fmoc chromophore and a naphthalene aromatic ring provides strong spectroscopic detectability, which can facilitate LC-MS or UV-based tracking of intermediates and residues in synthetic sequences. The D-stereochemistry and defined side-chain substitution pattern allow unambiguous identification of stereochemical incorporation when analyzing peptide products or fragments. The compound thus serves as a practical amino acid derivative standard for quality-relevant analytical workflows in peptide chemistry and industrial intermediate characterization.

1. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

2. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

3. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

4. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

5. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)